Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Study Information
Alliance Study ID: NCCTG-N10C1
NCT Study ID (ClinicalTrials.gov): NCT01376349
Alliance Committee: Cancer Control
Disease or Cancer Type: Breast Cancer, Gynecologic Cancers – Ovarian / Uterine / Cervical / Endometrial
Alliance Study Chair: Debra Barton, RN, PhD, AOCN, FAAN
Status: COMPLETED
Study Description
RATIONALE: Dehydroepiandrosterone (DHEA) may help relieve vaginal symptoms in female cancer survivors.
PURPOSE: This randomized phase III trial studies DHEA to see how well it works compared to placebo in treating postmenopausal cancer survivors with vaginal symptoms.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information